Benchmark Holdings PLC (AIM:BMK) said it has acquired the remaining 10.52% minority interest in its subsidiary, Benchmark Genetics Iceland.
According to a statement from the aquaculture biotech, Benchmark Genetics Iceland is core to the company’s ability to supply highly specialist, biosecure salmon eggs to salmon producers in roughly 35 countries all-year round, representing roughly half of the group’s salmon egg capacity.
"Benchmark's genetics operations in Iceland have a 200mln egg capacity and are core to our ability to supply highly biosecure salmon eggs year-round to customers around the world,” said chief executive Trond Williksen.
“The acquisition of the remaining minority interest is a natural step in delivering shareholder value through full ownership of the success of our genetics business."
The London-listed company purchased an 89.48% interest in Stofnfiskur back in December 2014, subsequently renaming it Benchmark Genetics Iceland and merging it with its Norwegian salmon genetics business.
Benchmark said the business has grown “substantially” since the acquisition, benefitting from Benchmark’s leading market position, investment and knowledge.